Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients
Open Access
- 6 October 2013
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 15 (11), 1552-1559
- https://doi.org/10.1093/neuonc/not121
Abstract
Background Ependymoma is treated with maximal surgical resection and localized radiotherapy. Minimizing unnecessary exposure to radiation is of paramount importance for young children. Proton radiotherapy (PRT) spares healthy tissues outside the target region, but reports of clinical outcomes are scarce. We report outcomes for 70 patients treated with PRT for intracranial ependymoma. Methods Seventy patients with localized ependymoma treated with involved-field PRT at the Massachusetts General Hospital between October 2000 and February 2011 were included. Results Median age at diagnosis was 38 months (range, 3 mo–20 y). Nineteen (27%) patients had supratentorial ependymoma and 51(73%) had infratentorial ependymoma. Forty-six (66%) had gross total resection (GTR), and 24 (34%) had subtotal resection (STR). At a median follow-up of 46 months, 3-year local control, progression-free survival, and overall survival were 83%, 76%, and 95%, respectively. STR was significantly associated with worse progression-free survival (54% vs 88%, P = .001) and overall survival (90% vs 97% for GTR, P = .001). In a subset of patients (n = 14), mean intelligence was 108.5 at baseline and 111.3 after mean 2.05 years of follow-up. In a larger group of patients (n = 28), overall adaptive skills were 100.1 at baseline and 100.8 after 2.21 years of follow-up. Few patients developed evidence of growth hormone deficiency, hypothyroidism, or hearing loss. Conclusion Outcomes for children treated with PRT compare favorably with the literature. STR correlated with inferior outcome. The young age at diagnosis and the proximity of critical structures in patients with ependymoma make PRT an ideal radiation modality.Keywords
This publication has 28 references indexed in Scilit:
- Growth Hormone Secretion After Conformal Radiation Therapy in Pediatric Patients With Localized Brain TumorsJournal of Clinical Oncology, 2011
- Pediatric infratentorial ependymoma: prognostic significance of anaplastic histologyJournal of Neuro-Oncology, 2011
- Post-operative radiation improves survival in children younger than 3 years with intracranial ependymomaJournal of Neuro-Oncology, 2011
- Preliminary Results From a Phase II Trial of Conformal Radiation Therapy and Evaluation of Radiation-Related CNS Effects for Pediatric Patients With Localized EpendymomaJournal of Clinical Oncology, 2004
- Multivariate Analysis of Clinical Prognostic Factors in Children with Intracranial EpendymomasJournal of Neuro-Oncology, 2004
- Radiation dose-volume effects on growth hormone secretionInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the german prospective trials hit 88/89 and hit 91International Journal of Radiation Oncology*Biology*Physics, 2000
- Thyroid abnormalities after therapeutic external radiationInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Intracranial ependymomas in childrenInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Growth and Endocrine Disorders Secondary to Cranial IrradiationPediatric Research, 1989